Clinical trials
No Disease or Condition is Being Studied clinical trials
Below are recruiting no disease or condition is being studied clinical trials, each written for real people, not researchers. We’re tracking 18,600 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06334666Enrolling by invitation
Step counting for fatty liver disease management
This trial tests if using a pedometer to track daily steps can help people with a type of fatty liver disease (called MASLD) become more active and improve their health. It may be a good fit if you are not already very active and want to try a simple way to manage your condition.
Bangkoknoi, BangkokAges 18 years+ - NCT06330324Enrolling by invitation
Reproductive choices for genetic skin conditions
This study looks at the choices families have when they carry a genetic skin condition. It aims to learn more about how prenatal testing and IVF with genetic testing can help.
Maastricht, LimburgAges Any age - NCT06311253Enrolling by invitation
Gum treatment with lactoferrin toothpaste in pregnancy
This study tests whether special toothpaste and mouthwash with lactoferrin (a natural protein) can help treat gum problems in pregnant women. It may offer a safe way to care for your gums during pregnancy.
Pavia, LombardyAges 18–40 - NCT06308497Enrolling by invitation
Periodontal treatment with CoQ10 and probiotics for pregnant women
This study tests whether a combination of coenzyme Q10 and probiotics can improve gum health in pregnant women. It aims to find a safe, gentle treatment for gum problems during pregnancy.
Pavia, LombardyAges 18–40 - NCT06303986Enrolling by invitation
Observation study for newborns with or without NAS
This study is collecting information from two groups of newborns: those with Neonatal Abstinence Syndrome (NAS, caused by drug exposure before birth) and healthy newborns. The goal is to see if an automated system makes it easier to gather data without extra tests or procedures.
Albuquerque, New MexicoAges Up to 4 weeks - NCT06285448Enrolling by invitation
Lecanemab registry and outcome study
This study looks at how well lecanemab (a new Alzheimer's treatment) works in real-world clinics. It also tracks how patients and their care partners do over time. If you are already getting or eligible for lecanemab, you might join with your care partner.
Saint Paul, MinnesotaAges 18 years+ - NCT06275620Enrolling by invitationPhase 2
Testing a gene therapy for X-linked retinitis pigmentosa in males
This trial tests two doses of a gene therapy (AGTC-501) in males who already had one eye treated with a similar gene therapy for X-linked retinitis pigmentosa caused by RPGR mutations. The goal is to see if the treatment is safe and can help preserve or improve vision.
Jacksonville, FloridaAges 12 years+ - NCT06270719Enrolling by invitation
Comparing ELEVIDYS to standard care for Duchenne muscular dystrophy
This study compares the gene therapy ELEVIDYS (delandistrogene moxeparvovec) to usual treatments for people with Duchenne muscular dystrophy (DMD). It helps researchers understand how well ELEVIDYS works over time in real-world settings.
Little Rock, ArkansasAges 4 years+ - NCT06264609Enrolling by invitationPhase 4
Precision follow-up study for osteoporosis treatment
This study is a follow-up for people who completed a previous precision medicine trial for osteoporosis. It will monitor your bone health to see how well the treatment is working over time.
Lexington, KentuckyAges 45 years+ - NCT06262282Enrolling by invitation
Phage therapy for stubborn NTM infection in cystic fibrosis
This trial tests whether a special virus therapy (phage) can help clear stubborn NTM lung infections in people with cystic fibrosis who have been on antibiotics for over a year without success. Participants will continue their antibiotics while receiving the phages.
Birmingham, AlabamaAges 6 years+ - NCT06261528Enrolling by invitationPhase 1
Light therapy for sleepiness in progressive MS
This trial tests whether a special light therapy can help people with progressive multiple sclerosis who feel sleepy during the day. It aims to improve energy, mood, and sleep patterns.
Dallas, TexasAges 18 years+ - NCT06243068Enrolling by invitation
Supporting decisions about kidney care without dialysis
This study helps people with advanced chronic kidney disease explore their care options, including the choice to manage without dialysis. It provides support and information to help you and your family make a decision that fits your values.
San Francisco, CaliforniaAges 65 years+ - NCT06232616Enrolling by invitation
Eye surgery with steroid implant for membrane-related swelling
This study tests combining vitrectomy (surgery to remove the membrane from the retina) with a dexamethasone implant (a tiny steroid that is placed inside the eye to reduce swelling) for people with a specific type of eye membrane and fluid buildup in the center of the retina.
Shanghai, Shanghai MunicipalityAges 40 years+ - NCT06230887Enrolling by invitation
New treatment for moral injury in veterans
This study tests a new therapy for veterans struggling with moral injury—distress from events that go against personal values. It compares two treatment approaches to see which works better.
Little Rock, ArkansasAges 18 years+ - NCT06223542RecruitingPhase 1
TAK-243 for advanced cancers that haven't responded to other treatments
This trial tests a new drug called TAK-243 for people with advanced cancers (solid tumors or lymphomas) that have not responded to other treatments. It aims to see if the drug is safe and how well it works.
Bethesda, MarylandAges 18 years+ - NCT06221592Enrolling by invitation
New glasses for slowing myopia in children
This study is testing the safety and comfort of new glasses with special lenses designed to slow down nearsightedness in children. It compares differences between the new lenses and regular lenses, and the child will wear them for a period of time to see how they feel and if there are any concerns.
Shanghai, Shanghai MunicipalityAges 6–14 - NCT06215846Enrolling by invitationPhase 1
Study of BioTTT001 for advanced solid tumors
This trial tests a new drug, BioTTT001, given as a shot directly into tumors. It is for people with certain advanced solid tumors that have stopped responding to standard treatments or who have no other options.
Shenyang, LiaoningAges 18–80 - NCT06179563Enrolling by invitation
On-demand app for IBD patients in remission
This trial tests an app that lets you check in with your IBD care team only when you need to, instead of having regular appointments. It's for people with Crohn's disease or ulcerative colitis who are doing well and have been on the same medication for at least 3 months.
's-Hertogenbosch, North BrabantAges 18 years+ - NCT06164756Enrolling by invitation
Long-term follow-up of the ketamine for Parkinson's trial
This study follows up on people with Parkinson's disease who took part in an earlier trial testing the effects of ketamine. It looks at how they do over a longer period of time.
New Haven, ConnecticutAges 40–80 - NCT06160557Enrolling by invitation
Radiation after endoscopic surgery for superficial esophageal cancer
This trial tests if adding radiation therapy after endoscopic surgery (ESD) helps people with early-stage esophageal cancer that had certain high-risk features, like deeper invasion or positive margins. It aims to improve outcomes for those who didn't get a complete cure with surgery alone.
Fuzhou, FujianAges 18–75 - NCT06158490Enrolling by invitationPhase 2
JYP0061 tablet for moderate to severe eczema
This trial tests a new tablet called JYP0061 for people with moderate to severe atopic dermatitis (eczema) that has lasted at least a year. It aims to see if the drug is safe and effective in reducing symptoms.
Shanghai, Shanghai MunicipalityAges 18–65 - NCT06155487Enrolling by invitationPhase 1
AJH-2947 safety study in healthy men
This trial tests the safety of a new oral drug, AJH-2947, in healthy Korean or Caucasian men. It helps determine how the body processes the drug and if it causes any side effects.
SeoulAges 19–55 - NCT06127277Enrolling by invitation
Mobile relationship program for youth in foster care
This study tests a fully mobile program designed to help youth in foster care build healthy relationships. If you join, you'll use an app on your device to learn skills and connect with others.
Berkeley, CaliforniaAges 16–19 - NCT06101940Enrolling by invitation
Chinese study tracking myotonic dystrophy type 1 outcomes
This study follows people with myotonic dystrophy type 1 (DM1) over time to learn more about how the disease progresses. It collects health information and samples to help improve care.
Beijing, Beijing MunicipalityAges Any age
Hear when a new No Disease or Condition is Being Studied trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for no disease or condition is being studied?
- Yes. Clin2 currently lists 18,600 recruiting no disease or condition is being studied studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a no disease or condition is being studied trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a no disease or condition is being studied trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.